Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma - results of a prospective multicentre controlled trial

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F06%3A00003498" target="_blank" >RIV/61989592:15110/06:00003498 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/06:00009650 RIV/00064165:_____/06:00001337 RIV/00216208:11120/06:00001182
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma - results of a prospective multicentre controlled trial
Original language description
Objectives: To explore the safety and effectiveness of the individually determined application granulocyte-colony stimulating factor (G-CSF) after autologou peripheral blood stem cell transplantation (ASCT).
Czech name
Individuálně určené dávkování filgrastimu po autologní transplantaci u pacientů s maligním lymfomem - výsledky prospektivní multicentricky řízené studie
Czech description
Objectives: To explore the safety and effectiveness of the individually determined application granulocyte-colony stimulating factor (G-CSF) after autologou peripheral blood stem cell transplantation (ASCT).

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description